222 related articles for article (PubMed ID: 15083213)
1. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
[TBL] [Abstract][Full Text] [Related]
2. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
Br J Cancer; 2003 Mar; 88(6):928-32. PubMed ID: 12644831
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
5. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer.
John EM; Schwartz GG; Koo J; Van Den Berg D; Ingles SA
Cancer Res; 2005 Jun; 65(12):5470-9. PubMed ID: 15958597
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
[TBL] [Abstract][Full Text] [Related]
7. Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.
Mullan RJ; Bergstralh EJ; Farmer SA; Jacobson DJ; Hebbring SJ; Cunningham JM; Thibodeau SN; Lieber MM; Jacobsen SJ; Roberts RO
Urology; 2006 Feb; 67(2):300-5. PubMed ID: 16461080
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer.
Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
Environ Mol Mutagen; 2004; 43(2):121-7. PubMed ID: 14991752
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
[TBL] [Abstract][Full Text] [Related]
10. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
Huang SP; Wu WJ; Chang WS; Wu MT; Chen YY; Chen YJ; Yu CC; Wu TT; Lee YH; Huang JK; Huang CH
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2217-24. PubMed ID: 15598783
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384
[TBL] [Abstract][Full Text] [Related]
12. Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.
Huang SP; Chou YH; Wayne Chang WS; Wu MT; Chen YY; Yu CC; Wu TT; Lee YH; Huang JK; Wu WJ; Huang CH
Cancer Lett; 2004 Apr; 207(1):69-77. PubMed ID: 15050735
[TBL] [Abstract][Full Text] [Related]
13. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
[TBL] [Abstract][Full Text] [Related]
14. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor polymorphisms and lethal prostate cancer.
Kibel AS; Isaacs SD; Isaacs WB; Bova GS
J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
[TBL] [Abstract][Full Text] [Related]
16. Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.
Watanabe M; Fukutome K; Murata M; Uemura H; Kubota Y; Kawamura J; Yatani R
Anticancer Res; 1999; 19(5C):4511-4. PubMed ID: 10650802
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
Ntais C; Polycarpou A; Ioannidis JP
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1395-402. PubMed ID: 14693728
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
Andersson P; Varenhorst E; Söderkvist P
Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
[TBL] [Abstract][Full Text] [Related]
19. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
Veronique-Baudin J; Dieye M; Kouyoumdjian JC; Vacheron F; Draganescu C; Azaloux H
Prog Urol; 2006 Jun; 16(3):303-10. PubMed ID: 16821341
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
